Sharing our perspective

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward.


  • Tennessee enacts enhanced opioid prescribing controls

    by
    • Optum Workers' Comp
    | Jun 01, 2018
    Tag Icon
    Opioids
    House Bill 1831 was recently signed by Tennessee’s Governor, which enacts prescribing restrictions on opioid analgesics; sets dose caps on morphine milligram equivalent (MME); and defines enhanced prescription drug monitoring program (PDMP) requirements. Effective July 1, 2018, the bill bases prescribing restrictions on various treatment timeframes and requires the prescriber to properly examine, justify and document the need for additional opioid treatment.


  • FDA approves first-in-class medication to prevent migraine

    by
    • Optum Workers' Comp
    | May 22, 2018
    Tag Icon
    Pain Management, FDA, Migraine
    The U.S. Food and Drug Administration (FDA) approved the first medication in a new class to prevent chronic migraine in adults. Aimovig™ (erenumab-aooe) will be marketed by Amgen Inc. as a self-administered, once monthly, subcutaneous (under the skin) injection.


  • FDA approves first non-opioid medication for opioid withdrawal symptoms

    by
    | May 17, 2018
    Tag Icon
    Workers' Compensation, Opioids
    the FDA approved Lucemyra™ (lofexidine hydrochloride) for the mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults.


  • National Prescription Drug Take Back Day Slated for April 28

    by
    • Optum Workers' Comp
    | Apr 17, 2018
    Tag Icon
    Overdose, DEA
    Saturday, April 28, from 10 a.m. to 2 p.m., is National Prescription Drug Take Back Day sponsored by the U.S. Drug Enforcement Administration (DEA). The purpose of National Prescription Drug Take Back Day is to provide a safe, convenient, and responsible way to dispose of prescription medications that are unwanted, unused, or expired, while also educating the public on the potential abuse of medications.